Sandu Pharma Standalone June 2024 Net Sales at Rs 17.05 crore, down 3.46% Y-o-Y
August 13, 2024 / 12:11 IST
Reported Standalone quarterly numbers for Sandu Pharmaceuticals are:Net Sales at Rs 17.05 crore in June 2024 down 3.46% from Rs. 17.66 crore in June 2023.
Quarterly Net Profit at Rs. 0.17 crore in June 2024 up 52.06% from Rs. 0.11 crore in June 2023.
EBITDA stands at Rs. 0.45 crore in June 2024 up 28.57% from Rs. 0.35 crore in June 2023.
Sandu Pharma EPS has increased to Rs. 0.17 in June 2024 from Rs. 0.11 in June 2023.
| Sandu Pharma shares closed at 59.80 on August 12, 2024 (BSE) and has given -15.80% returns over the last 6 months and 7.73% over the last 12 months. |
| Sandu Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 17.05 | 15.60 | 17.66 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 17.05 | 15.60 | 17.66 | | EXPENDITURE | | Consumption of Raw Materials | 2.27 | 2.84 | 1.98 | | Purchase of Traded Goods | 3.94 | 5.59 | 3.28 | | Increase/Decrease in Stocks | 3.08 | -2.24 | 4.19 | | Power & Fuel | -- | -- | -- | | Employees Cost | 2.33 | 2.47 | 2.52 | | Depreciation | 0.16 | 0.19 | 0.12 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.01 | 6.32 | 5.33 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.25 | 0.42 | 0.23 | | Other Income | 0.04 | 0.31 | 0.00 | | P/L Before Int., Excpt. Items & Tax | 0.29 | 0.72 | 0.23 | | Interest | 0.02 | 0.01 | 0.02 | | P/L Before Exceptional Items & Tax | 0.27 | 0.72 | 0.21 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.27 | 0.72 | 0.21 | | Tax | 0.10 | 0.12 | 0.10 | | P/L After Tax from Ordinary Activities | 0.17 | 0.59 | 0.11 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.17 | 0.59 | 0.11 | | Equity Share Capital | 9.66 | 9.66 | 9.66 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.17 | 0.50 | 0.11 | | Diluted EPS | 0.17 | 0.50 | 0.11 | | EPS After Extra Ordinary | | Basic EPS | 0.17 | 0.50 | 0.11 | | Diluted EPS | 0.17 | 0.50 | 0.11 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
